Latest stories on MNKD
MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
Yahoo Top58 · neutralproduct/pr
MannKind At An Inflection Point: Pediatric Expansion Drives The Story
Seeking Alpha77 · bullishproduct/pr
MannKind Gains FDA Approval for Afrezza Pediatric Use
TipRanks86 · bullishproduct/pr
MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript
Seeking Alpha67 · bullishproduct/pr
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval | MNKD Stock News
StockTitan67 · bullishproduct/pr
MannKind gains FDA nod to expand inhaled insulin for children
Seeking Alpha77 · bullishproduct/pr
MannKind Released From Major Afrezza Trial Obligation
TipRanks61 · neutralproduct/pr
MannKind to Present at Jefferies Global Healthcare Conference | MNKD Stock News
StockTitan53 · neutralproduct/pr
MannKind Shareholders Reaffirm Board, Pay, and Auditor Roles
TipRanks50 · neutralgeneral
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M
Yahoo Top68 · bullishearnings
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
Yahoo Finance61 · neutralanalyst
MannKind (MNKD) Q1 2026 Earnings Transcript
Yahoo Top50 · neutralearnings